ARE THERE GENDER SPECIFIC DIFFERENCES IN PATIENT REPORTED OUTCOMES AT INITIATION OF GOLIMUMAB TREATMENT IN RHEUMATOID ARTHRITIS?

被引：0

作者：

Sholter, D. ^{[1
]}

Bensen, W. G. ^{[2
,3
]}

Choquette, D. ^{[4
]}

Fortin, I. ^{[5
]}

Arendse, R. ^{[6
]}

Kelsall, J. ^{[7
]}

Sheriff, M. ^{[8
]}

Faraawi, R. ^{[9
]}

Rodrigues, J. ^{[10
]}

Zummer, M. ^{[11
,12
]}

Dixit, S. ^{[9
]}

Starr, M. ^{[4
]}

Rampakakis, E. ^{[13
,14
]}

Sampalis, J. S. ^{[13
,14
]}

Nantel, F. ^{[15
]}

Shawi, M. ^{[15
]}

Otawa, S. ^{[15
]}

Lehman, A. J. ^{[15
]}

机构：

[1] Univ Alberta, Edmonton, AB, Canada

[2] St Joseph Hosp, Hamilton, ON, Canada

[3] McMaster Univ, Hamilton, ON, Canada

[4] Montreal Gen Hosp, Montreal, PQ H3G 1A4, Canada

[5] Ctr Rhumatol Est Quebec, Rimouski, PQ, Canada

[6] Univ Saskatchewan, Saskatoon, SK, Canada

[7] Mary Pack Arthrit Ctr, Vancouver, BC, Canada

[8] Nanaimo Reg Gen Hosp, Nanaimo, BC, Canada

[9] McMaster Univ, Hamilton, ON, Canada

[10] Clin Res & Arthrit Ctr, Windsor, ON, Canada

[11] Univ Montreal, Montreal, PQ, Canada

[12] Hop Maison Neuve Rosemont, Montreal, PQ, Canada

[13] McGill Univ, Montreal, PQ, Canada

[14] JSS Med Res, Montreal, PQ, Canada

[15] Janssen Inc Canada, Toronto, ON, Canada

来源：

ANNALS OF THE RHEUMATIC DISEASES | 2014年 / 73卷

关键词：

D O I：

10.1136/annrheumdis-2014-eular.3979

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

AB1044

引用

页码：1145 / 1145

页数：1

共 50 条

[21] Patient Reported Outcomes in Rheumatoid Arthritis Clinical Trials
Orbai, Ana-Maria
Bingham, Clifton O., III
CURRENT RHEUMATOLOGY REPORTS, 2015, 17 (04)
[22] Patient Reported Outcomes in Rheumatoid Arthritis Clinical Trials
Ana-Maria Orbai
Clifton O. Bingham
Current Rheumatology Reports, 2015, 17
[23] Sarilumab: patient-reported outcomes in rheumatoid arthritis
Crotti, Chiara
Biggioggero, Martina
Becciolini, Andrea
Favalli, Ennio Giulio
PATIENT-RELATED OUTCOME MEASURES, 2018, 9 : 275 - 284
[24] Gender-specific differences in comorbidities of rheumatoid arthritis
Albrecht, K.
ZEITSCHRIFT FUR RHEUMATOLOGIE, 2014, 73 (07): : 607 - 614
[25] PATIENT EVALUATIONS OF AUTOINJECTORS FOR DELIVERY OF SUBCUTANEOUS GOLIMUMAB FOR TREATMENT OF RHEUMATOID ARTHRITIS
Schulze-Koops, H.
Giacomelli, R.
Samborski, W.
Rednic, S.
Herold, M.
Yao, R.
Govoni, M.
Vastesaeger, N.
Weng, H. H.
ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 230 - 231
[26] GOLIMUMAB IMPROVES QUALITY OF LIFE AND OTHER PATIENT-REPORTED OUTCOMES IN PATIENTS WITH RHEUMATOID ARTHRITIS, IN REAL-WORLD CONDITIONS
Psaltis, D.
Settas, L.
Georgiadis, A.
Koukli, E.
Bounas, A.
Haratsis, I
Petrikkou, E.
Kalogiannaki, E.
Sidiropoulos, P.
Vassilopoulos, D.
VALUE IN HEALTH, 2019, 22 : S432 - S433
[27] Clinical and patient-reported outcomes in clinical trials of abatacept in the treatment of rheumatoid arthritis
Massarotti, Elena M.
CLINICAL THERAPEUTICS, 2008, 30 (03) : 429 - 442
[28] EARLY ONSET OF BENEFIT BY PATIENT-REPORTED OUTCOMES WITH SARILUMAB TREATMENT IN RHEUMATOID ARTHRITIS
Strand, Vibeke
Chen, Cheih-I
Mahajan, Sunny
Kosinski, Mark
Mangan, Erin K.
van Hoogstraten, Hubert
Graham, Neil
Lin, Yong
Keystone, Edward
Braun, Juergen
RHEUMATOLOGY, 2017, 56 : 137 - 137
[29] Sensitivity of measures of patient reported outcomes following treatment with abatacept in patients with rheumatoid arthritis
Wells, G.
Li, T.
Maxwell, L.
Maclean, R.
Tugwell, P.
ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 607 - 607
[30] PATIENT-REPORTED OUTCOMES RELATED TO ADVERSE EVENTS DURING RHEUMATOID ARTHRITIS TREATMENT
Feinberg, B. A.
Burruss, R. A.
Olson, T.
Malik, F.
Oleru, K.
Garofalo, D. F.
VALUE IN HEALTH, 2016, 19 (03) : A237 - A237

← 1 2 3 4 5 →